Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
Skip to contentJohnson & Johnson COVID-19 Vaccinations Resume Following CDC and FDA Decision
Our Company
Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
New Brunswick, NJ (May 7, 2021) — Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference on Tuesday, June 8th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:40 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately 48 hours after the live webcast.
###
- Press Contacts:
Christina Chan
(732) 524-6297Investor Contacts:
Christopher DelOrefice
(732) 524-2955Jennifer McIntyre
(732) 524-3922
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
